Kcnip1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Kcnip1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
KCNIP1 (KV Channel Interacting Protein 1) encodes a calcium-sensitive regulatory subunit of voltage-gated potassium channels.
| Attribute | Value |
|---|---|
| Gene Symbol | KCNIP1 |
| Full Name | KV Channel Interacting Protein 1 |
| Chromosomal Location | 5q32 |
| PMID | 80321 |
| Ensembl ID | ENSG00000160072 |
| UniProt ID | Q9Y2R9 |
KCNIP1 (KChiP1) modulates Kv4 channel function, affecting A-type potassium currents.
| Disease | Variant | Notes |
|---|---|---|
| Temporal lobe epilepsy | Risk variants | Altered neuronal excitability |
| Autism | Risk variants | Synaptic function |
High expression in:
Kcnip1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Kcnip1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52(4):557-594. PMID:10893102.
Wei AD, Gutman GA, Aldrich R, et al. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev. 2005;57(4):473-492. PMID:16382103.
Coetzee WA, Amarillo Y, Chiu J, et al. Molecular diversity of K+ channel function and structure. Annu Rev Physiol. 1999;61:173-198. PMID:10099684.
Rudy B, Sen K, Vega-Beltrán J, et al. The Kv3 channels: voltage-gated K+ channels highly expressed in brain. Adv Exp Med Biol. 1999;463:159-169. PMID:10352670.
Hille B. Ion channels of excitable membranes. 3rd ed. Sunderland, MA: Sinauer Associates; 2001.
6.宴 K+ channel dysfunction in neurodegenerative diseases. Nat Rev Neurosci. 2018;19(8):485-498. DOI:10.1038/s41583-018-0035-4
Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev. 2005;85(4):1205-1253. PMID:16183911.
Stocker M. Ca2+-activated K+ channels: molecular determinants and function. Trends Neurosci. 2004;27(6):303-307. PMID:15165735.